MoneyWorks4Me

The sales for the March 2025 quarter moved up 25.77% to Rs. 1156.76 millions as compared to Rs. 919.77 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 144.99 millions  from Rs. 44.96 millions in the quarter ended March 2025.Operating Profit saw a handsome growth to 266.64 millions from 214.42 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1156.76 919.77 25.77 3701.97 3071.72 20.52 3701.97 3071.72 20.52
Other Income 7.65 5.83 31.22 19.20 18.30 4.92 19.20 18.30 4.92
PBIDT 266.64 214.42 24.35 823.64 684.63 20.30 823.64 684.63 20.30
Interest 24.92 30.57 -18.48 98.78 103.87 -4.90 98.78 103.87 -4.90
PBDT 241.72 112.86 114.18 724.86 509.77 42.19 724.86 509.77 42.19
Depreciation 50.79 50.43 0.71 182.58 195.11 -6.42 182.58 195.11 -6.42
PBT 190.93 62.43 205.83 542.28 314.66 72.34 542.28 314.66 72.34
TAX 45.94 17.47 162.97 143.38 74.83 91.61 143.38 74.83 91.61
Deferred Tax -15.87 1.76 -1001.70 -15.89 -4.37 263.62 -15.89 -4.37 263.62
PAT 144.99 44.96 222.49 398.90 239.83 66.33 398.90 239.83 66.33
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 23.05 23.31 -1.12 22.25 22.29 -0.18 22.25 22.29 -0.18
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..